12,372 trials
Epilepsy
Primary: Number of Participants Who Were Seizure Free in the Maintenance Phase (Across Seizure Types and by Seizure Type Within 6 Months Prior to the Start of the Study) — 28…
Type 2 Diabetes Mellitus
Primary: Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 52 — -0.81; -0.76; -0.73 percentage glycosylated hemoglobin
Carcinoma, Renal Cell
Primary: Number of Participants With Any Adverse Event (AE) or Serious Adverse Event (SAE) — 78; 27 participants
Parkinson's Disease
Primary: Change From Baseline in Mean Total Daily OFF Time Using Parkinson's Disease Patient Diary — -1.24; -1.59 hours — p=0.3257
Infections, Papillomavirus
Primary: Number of Seroconverted Subjects Against Human Papillomavirus-16 (HPV-16) and HPV-18 — 345; 67; 363; 135 Participants
Hyperglycemia · Critical Illness
Primary: All-cause 90-day Mortality — 431; 447 participants
Lateral Canthus Rhytides · Crow's Feet Lines
Primary: Percentage of Responders Based on Composite Facial Wrinkle Scale Assessment of Crow's Feet Line Severity at Maximum Smile — 25.7; 1.3 Percentage of participants
Facial Rhytides · Crow's Feet Lines · Glabellar Lines
Primary: Percentage of Responders Based on Composite Facial Wrinkle Scale Assessment of Crow's Feet Line Severity at Maximum Smile — 21.3; 20.6; 0.0 Percentage of participants
Meningitis · Meningococcal Disease
Primary: Percentage of Participants With Seroconversion Following Vaccination With Either Menactra® or Adacel® Vaccine — 78; 9; 88; 8 Percentage of participants
Multiple Sclerosis, Relapsing-Remitting
Primary: Annualized Qualifying Relapse Rate — 0.15; 0.14; 0.33 relapses per year — p=<0.001
Relapsing-Remitting Multiple Sclerosis
Primary: Safety Population: Percentage of Participants With at Least 1 Common Terminology Criteria for Adverse Events Version 3.0 (CTCAE) Grade 4 Hematologic and Hepatic Toxicity…
Encephalitis · Japanese Encephalitis
Primary: Number of Participants With Japanese Encephalitis Seroconversion After Vaccination With One Dose of Either Japanese Encephalitis Chimeric Vaccine (JE-CV) or Japanese…
Nonfluent Aphasia · Stroke
Primary: Language Quotient (LQ) on the Western Aphasia Battery — 3.16; 2.59 units on a scale
Non-small Cell Lung Cancer
Primary: Overall Survival — 12.55; 13.40 months — p=0.94896
Dry Eye Syndrome
Primary: Tear Film Evaporation Rate — 26.0 10^-7g/cm^2/sec